Congenital Bleeding Disorders
📧 Sign up to get email alerts when something new happens for Congenital Bleeding Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 [Phase 3]
A Phase 3 extension study reports on long-term safety and efficacy of NNC-0156-0000-0009 in patients with Haemophilia B, supplementing NN799…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Survey Evaluating the Psychosocial Effects of Living With Haemophilia
A completed clinical trial update describing a survey evaluating the psychosocial effects of living with haemophilia and related congenital …
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Input of a Multidisciplinary Device to Accompany the Announce of Diagnosis for Young Children With Serious Constitutional Hemorrhagic Disease and Their Families [NA]
This update notes the completion of a clinical trial evaluating a multidisciplinary device to accompany the diagnosis announcement for young…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers [Phase 1]
A Phase 1 study evaluating the safety and local tolerability of escalating doses of a long-acting activated recombinant human Factor VII in …
-
CLINICAL_TRIALS withdrawal · 2014-03-26Clinical Trial Update: Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects [Phase 1]
A Phase 1 bioequivalence trial comparing Eptacog Alfa A 6 mg to NovoSeven in healthy male subjects has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.